Chris Rallis
Director/Board Member en AEOLUS PHARMACEUTICALS, INC. .
Fortuna: 509 719 $ al 31/03/2024
Perfil
Chris A.
Rallis is an Independent Director at Fennec Pharmaceuticals, Inc., Aeolus Pharmaceuticals, Inc., and Salisbury School, Inc. He was previously the President & Chief Executive Officer at ImmunoBiosciences, Inc. and President, Chief Operating Officer & Director at Triangle Pharmaceuticals, Inc. He also served as a Director at Incara Pharmaceuticals Corp.
and as VP-Strategic Planning & Business Development at Burroughs Wellcome.
Rallis holds a graduate degree from Duke University and an undergraduate degree from Harvard College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2024 | 45 838 ( 0.17% ) | 509 719 $ | 31/03/2024 |
Cargos activos de Chris Rallis
| Empresas | Cargo | Inicio |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 01/06/2004 |
| FENNEC PHARMACEUTICALS INC. | Director/Board Member | 25/08/2011 |
| Salisbury School, Inc. | Director/Board Member | - |
Antiguos cargos conocidos de Chris Rallis.
| Empresas | Cargo | Fin |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Director/Board Member | 10/06/2021 |
ImmunoBiosciences, Inc.
 ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | 01/06/2007 |
| Incara Pharmaceuticals Corp. | Director/Board Member | 09/08/2004 |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | President | 01/01/2003 |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Chief Executive Officer | - |
Formación de Chris Rallis.
| Duke University | Graduate Degree |
| Harvard College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| FENNEC PHARMACEUTICALS INC. | Health Technology |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
| Incara Pharmaceuticals Corp. | Health Technology |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Technology Services |
| Burroughs Wellcome | |
| Salisbury School, Inc. |
- Bolsa de valores
- Insiders
- Chris Rallis
